Big Guy v. Little Guy
It started off as a perfect relationship: diagnostic giant Boehringer Mannheim and tiny Igen would jointly develop an immunoassay analyzer based on Igen's impressive new electrochemiluminesence (ECL) technology. Now the two companies find themselves in court, with Igen charging, among other things, that BMC didn't calculate royalties fairly and BMC seeking to retain rights to sell the ECL analyzer.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.